Children
ddI (didanosine, Videx / VidexEC) is safe and effective for use in children aged two weeks and over[1][2][3].
ddI is available as a buffered powder for children, which is dissolved in water before use. The recommended dose for children aged between two weeks and eight months is 100mg/m2 twice daily, although studies have found that half of this dose may be appropriate for children under four months of age[4]. For children over eight months the recommended dose is 120mg/m2 twice a day.
ddI tablets are also safe and effective in children[5].
Side-effects are similar in children and adults, although children are more likely to get a rare side-effect that can damage the eyes[6][7][8][9][10].
latest aidsmap news
- Unsuccessful post-exposure prophylaxis may still result in weaker HIV infection and lower viral load
- Jury still out on whether circumcision protects gay men against HIV
- Antiretroviral therapy does not fully reverse impact of HIV on hepatitis C-related cirrhosis
- High early mortality after starting antiretroviral treatment in Africa
- Nobel prize awarded to French discoverers of HIV
- Fall in number of undiagnosed HIV infections in the US
- Resistance to darunavir related to pre-existing mutations
- Higher levels of drug resistance seen after first-line NNRTI failure than boosted PI failure: meta-analysis
- Wide variation found in anal HPV viral loads in HIV-positive men
- Offering rapid point-of-care tests would increase uptake of HIV testing